|
US4194047A
(en)
|
1975-11-21 |
1980-03-18 |
Merck & Co., Inc. |
Substituted N-methylene derivatives of thienamycin
|
|
US4260543A
(en)
|
1978-07-03 |
1981-04-07 |
Merck & Co., Inc. |
Crystalline N-formimidoyl thienamycin
|
|
US4409214A
(en)
|
1979-11-19 |
1983-10-11 |
Fujisawa Pharmaceutical, Co., Ltd. |
7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US4822786A
(en)
|
1986-07-01 |
1989-04-18 |
Kaken Pharmaceutical Co., Ltd. |
Cephalosporin compounds, and antibacterial agents
|
|
ZA893284B
(en)
|
1988-05-04 |
1990-03-28 |
Igen Inc |
Peptide analogs and their use as haptens to elicit catalytic antibodies
|
|
US5888998A
(en)
|
1997-04-24 |
1999-03-30 |
Synphar Laboratories, Inc. |
2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
|
|
US6184363B1
(en)
|
1997-06-13 |
2001-02-06 |
Northwestern University |
Inhibitors of β-lactamases and uses therefor
|
|
EP1009415A4
(en)
|
1997-06-13 |
2000-10-25 |
Univ Northwestern |
INHIBITORS OF $g(b)-LACTAMASES AND USES THEREFOR
|
|
AU3124300A
(en)
|
1998-12-16 |
2000-07-03 |
Northwestern University |
Inhibitors of beta-lactamases and uses therefor
|
|
AU2190400A
(en)
|
1998-12-16 |
2000-07-03 |
Northwestern University |
Inhibitors of beta-lactamases and uses therefor
|
|
PL362900A1
(en)
|
1999-09-25 |
2004-11-02 |
Smithkline Beecham P.L.C. |
Piperazine derivatives as 5-ht1b antagonists
|
|
CA2388077A1
(en)
|
1999-10-28 |
2001-05-03 |
James M. Balkovec |
Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
|
|
WO2002022137A1
(en)
|
2000-09-12 |
2002-03-21 |
Shoichet Brian K |
β-LACTAM ANALOGS AND USES THEREFOR
|
|
BR0113861A
(pt)
|
2000-09-14 |
2004-01-27 |
Pantherix Ltd |
Derivados de ácidos 3-(heteroaril acetamido)-2-oxo-azetidina-1-sulfÈnicos como agentes antibacterianos
|
|
AU2002243508A1
(en)
|
2001-01-10 |
2002-07-24 |
Bristol-Myers Squibb Company Patent Department |
Alpha-aminoboronic acids prepared by novel synthetic methods
|
|
DE10118698A1
(de)
|
2001-04-17 |
2002-11-07 |
Jerini Ag |
Verfahren zur Immobilisierung und damit hergestellte Anordnungen von Verbindungen auf einer planaren Oberfläche
|
|
FR2835186B1
(fr)
|
2002-01-28 |
2006-10-20 |
Aventis Pharma Sa |
Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
|
|
JP2003229277A
(ja)
|
2002-02-04 |
2003-08-15 |
Matsushita Electric Ind Co Ltd |
発光素子材料およびそれを用いた発光素子並びに装置
|
|
AUPS065102A0
(en)
|
2002-02-20 |
2002-03-14 |
Unisearch Limited |
Fluorous acetalation
|
|
WO2004024697A1
(ja)
|
2002-09-11 |
2004-03-25 |
Kureha Chemical Industry Company, Limited |
アミン化合物及びその用途
|
|
EP2325224A1
(en)
|
2002-10-30 |
2011-05-25 |
Sumitomo Chemical Company, Limited |
Aryl copolymer compounds and polymer light emitting devices made by using the same
|
|
US7439253B2
(en)
|
2002-12-06 |
2008-10-21 |
Novexel |
Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
|
|
US7271186B1
(en)
|
2002-12-09 |
2007-09-18 |
Northwestern University |
Nanomolar β-lactamase inhibitors
|
|
US20060194825A1
(en)
|
2002-12-20 |
2006-08-31 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
|
TW200418791A
(en)
|
2003-01-23 |
2004-10-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions for inhibiting proteasome
|
|
JP4233365B2
(ja)
|
2003-03-25 |
2009-03-04 |
三井化学株式会社 |
アザジオール錯体化合物、及び該化合物を用いる光記録媒体
|
|
WO2005033090A1
(ja)
|
2003-10-06 |
2005-04-14 |
Sumitomo Chemical Company, Limited |
芳香族化合物
|
|
CA2541832C
(en)
|
2003-10-10 |
2009-11-24 |
Pfizer Products Inc. |
Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors
|
|
TW200600494A
(en)
|
2004-03-08 |
2006-01-01 |
Chugai Pharmaceutical Co Ltd |
Bisphenyl compounds useful as vitamin d3 receptor agonists
|
|
US20060019116A1
(en)
|
2004-07-22 |
2006-01-26 |
Eastman Kodak Company |
White electroluminescent device with anthracene derivative host
|
|
US20060178357A1
(en)
|
2005-02-10 |
2006-08-10 |
Buynak John D |
Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases
|
|
ES2872962T3
(es)
|
2005-02-16 |
2021-11-03 |
Anacor Pharmaceuticals Inc |
Boronoftalidas para uso terapéutico
|
|
TWI345562B
(en)
|
2005-02-22 |
2011-07-21 |
Teva Pharma |
Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
|
|
WO2006101779A2
(en)
|
2005-03-15 |
2006-09-28 |
The University Of Chicago |
Non-aqueous electrolytes for lithium ion batteries
|
|
TW200734311A
(en)
|
2005-11-21 |
2007-09-16 |
Astrazeneca Ab |
New compounds
|
|
SI1965798T1
(sl)
|
2005-12-07 |
2012-01-31 |
Basilea Pharmaceutica Ag |
Uporabni monobaktamski antibiotiki
|
|
SI1988779T1
(sl)
|
2006-02-16 |
2015-08-31 |
Anacor Pharmaceuticals, Inc. |
Bor-vsebujoče majhne molekule kot protivnetna sredstva
|
|
EP2069347A2
(en)
|
2006-09-27 |
2009-06-17 |
Merck & Co., Inc. |
Novel inhibitors of beta-lactamase
|
|
NZ579375A
(en)
|
2007-03-23 |
2012-02-24 |
Basilea Pharmaceutica Ag |
Combination medicaments for treating bacterial infections
|
|
GB0719366D0
(en)
|
2007-10-03 |
2007-11-14 |
Smithkline Beecham Corp |
Compounds
|
|
US20100120715A1
(en)
|
2007-11-13 |
2010-05-13 |
Burns Christopher J |
Beta-lactamase inhibitors
|
|
MX2010005250A
(es)
*
|
2007-11-13 |
2010-11-05 |
Novartis Int Pharm Ltd |
Inhibidores de beta-lactamasa.
|
|
PT2666774E
(pt)
|
2008-01-18 |
2015-04-13 |
Merck Sharp & Dohme |
Inibidores de beta-lactamase
|
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
|
US20100256092A1
(en)
|
2008-05-12 |
2010-10-07 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
|
WO2009139834A1
(en)
|
2008-05-13 |
2009-11-19 |
Poniard Pharmaceuticals, Inc. |
Bioactive compounds for treatment of cancer and neurodegenerative diseases
|
|
US20120046242A1
(en)
|
2008-12-24 |
2012-02-23 |
Massachusetts Institute Of Technology |
Molecular activators of the wnt/beta-catenin pathway
|
|
WO2010097675A1
(en)
|
2009-02-27 |
2010-09-02 |
Dhanuka Laboratories Ltd. |
An improved preparation process for cefpodoxime proxetil
|
|
AR076667A1
(es)
*
|
2009-05-12 |
2011-06-29 |
Novartis Int Pharm Ltd |
Inhibidores de beta-lactamasa
|
|
JP2012529511A
(ja)
|
2009-06-08 |
2012-11-22 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
トリアジン誘導体類及びそれらの治療応用
|
|
RU2012107163A
(ru)
|
2009-07-28 |
2013-09-10 |
Анакор Фармасьютикалз, Инк. |
Тризамещенные борсодержащие молекулы
|
|
EP2539348A4
(en)
|
2010-02-26 |
2013-07-24 |
Gary Igor Dmitrienko |
CEPHALOSPORIN DERIVATIVES AS BETA LACTAMASE HEMMER AND COMPOSITIONS THEREFOR AND METHOD FOR THEIR USE
|
|
US20110288063A1
(en)
|
2010-05-19 |
2011-11-24 |
Naeja Pharmaceutical Inc. |
Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
|
|
JP6266978B2
(ja)
|
2010-08-10 |
2018-01-24 |
レンペックス・ファーマシューティカルズ・インコーポレイテッド |
環状ボロン酸エステル誘導体およびその治療的使用
|
|
AU2011329486A1
(en)
|
2010-11-18 |
2013-04-18 |
Glaxo Group Limited |
Compounds
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
EP2508506A1
(en)
*
|
2011-04-08 |
2012-10-10 |
LEK Pharmaceuticals d.d. |
Preparation of sitagliptin intermediates
|
|
US9012491B2
(en)
|
2011-08-31 |
2015-04-21 |
Rempex Pharmaceuticals, Inc. |
Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
WO2013053372A1
(en)
|
2011-10-13 |
2013-04-18 |
Therabor Pharmaceuticals |
Boronic acid inhibitors of beta-lactamases
|
|
WO2013056163A1
(en)
|
2011-10-14 |
2013-04-18 |
The Regents Of The University Of California |
Beta-lactamase inhibitors
|
|
JP6129203B2
(ja)
*
|
2011-12-22 |
2017-05-17 |
アレス トレーディング ソシエテ アノニム |
α−アミノボロン酸誘導体、選択性免疫プロテアソーム阻害剤
|
|
CA2862710A1
(en)
*
|
2012-01-09 |
2013-07-18 |
University Of Tromso |
Therapeutic boron-containing compounds
|
|
WO2013122888A2
(en)
|
2012-02-15 |
2013-08-22 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|
|
US9156858B2
(en)
|
2012-05-23 |
2015-10-13 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US10561675B2
(en)
|
2012-06-06 |
2020-02-18 |
Rempex Pharmaceuticals, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
EP2928898B1
(en)
|
2012-12-07 |
2021-04-14 |
Venatorx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
US9241947B2
(en)
|
2013-01-04 |
2016-01-26 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9101638B2
(en)
|
2013-01-04 |
2015-08-11 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
BR112015016001A2
(pt)
|
2013-01-04 |
2017-07-11 |
Rempex Pharmaceuticals Inc |
compostos, composições farmacêuticas e respectivos usos e método para tratar ou prevenir infecção bacteriana
|
|
CN105101970B
(zh)
|
2013-01-10 |
2018-11-20 |
维纳拓尔斯制药公司 |
β-内酰胺酶抑制剂
|
|
EP2970340B1
(en)
|
2013-03-14 |
2020-02-12 |
Venatorx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|